Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
-
Published:2022-12
Issue:
Volume:34
Page:100842
-
ISSN:1476-5586
-
Container-title:Neoplasia
-
language:en
-
Short-container-title:Neoplasia
Author:
Bellerba FedericaORCID, Serrano DavideORCID, Johansson HarrietORCID, Pozzi ChiaraORCID, Segata Nicola, NabiNejad AmirORCID, Piperni ElisaORCID, Gnagnarella Patrizia, Macis DeboraORCID, Aristarco Valentina, Accornero Chiara A., Manghi PaoloORCID, Guerrieri-Gonzaga AlianaORCID, Biffi Roberto, Bottiglieri Luca, Trovato CristinaORCID, Zampino Maria Giulia, Corso FedericaORCID, Bellocco RinoORCID, Raimondi SaraORCID, Rescigno Maria, Gandini Sara
Reference51 articles.
1. Microbiota in health and diseases;Hou;Signal Transduct Target Ther 2022,2022 2. The role of the gut microbiota in colorectal cancer causation;Alhinai;Int J Mol Sci,2019 3. Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. 25, 667–678 (2019). 4. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion;Okumura;Nat Commun,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|